Article
Genomic Characterization of Metformin Hepatic Response.
PLoS genetics - 1 Nov 2016
Luizon Marcelo R, Eckalbar Walter L, Wang Yao, Jones Stacy L, Smith Robin P, Laurance Megan, Lin Lawrence, Gallins Paul J, Etheridge Amy S, Wright Fred, Zhou Yihui, Molony Cliona, Innocenti Federico, Yee Sook Wah, Giacomini Kathleen M, Ahituv Nadav
Abstract excerpt
Metformin is used as a first-line therapy for type 2 diabetes (T2D) and prescribed for numerous other diseases. However, its mechanism of action in the liver has yet to be characterized in a systematic manner. To comprehensively identify genes and regulatory elements associated with metformin treatment, we carried out RNA-seq and ChIP-seq (H3K27ac, H3K27me3) on primary human hepatocytes from the same donor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
